Barrow, Hanley, Mewhinney & Strauss’s ModivCare MODV Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio MODV Stock Details MODV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-650,936	Closed	-$7.71M	–	339
2024 Q4	$7.71M	Sell	650,936 -29,089	-4%	-$460K	0.03%	139
2024 Q3	$9.71M	Sell	680,025 -3,640	-0.5%	-$83.5K	0.03%	138
2024 Q2	$17.9M	Buy	683,665 +5,644	+0.8%	+$143K	0.06%	132
2024 Q1	$15.9M	Buy	+678,021	New	+$24.8M	0.05%	131
2018 Q4	–	Sell	-44,363	Closed	-$2.98M	–	381
2018 Q3	$2.98M	Sell	44,363 -29,447	-40%	-$2.05M	﹤0.01%	245
2018 Q2	$5.8M	Sell	73,810 -127	-0.2%	-$9.53K	0.01%	189
2018 Q1	$5.11M	Buy	73,937 +51,091	+224%	+$3.33M	0.01%	204
2017 Q4	$1.35M	Buy	+22,846	New	+$1.29M	﹤0.01%	299

Other funds holding MODV

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's MODV Position: Q1 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of ModivCare (MODV) in Q1 2025, closing a stake of 650,936 shares — an estimated $7.71M sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in MODV in Q4 2017 and held it in 8 quarters. The position peaked at $17.9M in Q2 2024. 91 funds tracked by Wall St. Rank hold MODV as of Q1 2025.

Barrow, Hanley, Mewhinney & Strauss reported no remaining ModivCare position as of Q1 2025 after selling out during the quarter.
Barrow, Hanley, Mewhinney & Strauss sold 650,936 ModivCare shares in Q1 2025, an estimated $7.71M.
Barrow, Hanley, Mewhinney & Strauss first reported a position in ModivCare in Q4 2017 and held it in 8 quarters.
Barrow, Hanley, Mewhinney & Strauss's ModivCare position peaked at $17.9M in Q2 2024.
91 funds tracked by Wall St. Rank held ModivCare as of Q1 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2025, filed 12 May 2025.